Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Valverde · SciRah

Researcher profile · Semantic Scholar

C. Valverde

Share profile

C. Valverde — researcher profile on SciRah

h-index: 27
Works: 114
Citations: 2,293

Most-cited papers

An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG)
B. Kasper, C. Baumgarten, J. García, S. Bonvalot +28 more
2017Annals of Oncology391 citations Open access
Semantic Scholar
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial
J. Martin Broto, N. Hindi, G. Grignani, J. Martínez-Trufero +16 more
2020Journal for ImmunoTherapy of Cancer162 citations Open access
Semantic Scholar
GEIS guidelines for gastrointestinal sarcomas (GIST).
A. Poveda, Xavier García del Muro, J. López-Guerrero, R. Cubedo +5 more
2017Cancer Treatment Reviews140 citations Open access
Semantic Scholar
SELNET clinical practice guidelines for soft tissue sarcoma and GIST.
J. Blay, N. Hindi, J. Bollard, S. Aguiar +60 more
2021Cancer Treatment Reviews69 citations Open access
Semantic Scholar
Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS).
J. Martin Broto, N. Hindi, J. Cruz, J. Martínez-Trufero +16 more
2018The Oncologist68 citations Open access
Semantic Scholar
Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
Xavier García del Muro, E. de Álava, V. Artigas, S. Bagué +10 more
2015Cancer Chemotherapy and Pharmacology60 citations Open access
Semantic Scholar
RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas
C. Serrano, C. Romagosa, J. Hernández-Losa, S. Simonetti +9 more
2016Cancer58 citations Open access
Semantic Scholar
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)
J. Martin Broto, A. Redondo, C. Valverde, M. Vaz +17 more
2017Annals of Oncology57 citations Open access
Semantic Scholar
The sacral chordoma margin.
S. Radaelli, P. Fossati, S. Stacchiotti, T. Akiyama +64 more
2020European Journal of Surgical Oncology56 citations Open access
Semantic Scholar
Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)
J. Pérez-Fidalgo, E. Ortega, J. Ponce, A. Redondo +7 more
2023Therapeutic Advances in Medical Oncology54 citations Open access
Semantic Scholar
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors
C. Serrano, A. Vivancos, A. López-Pousa, J. Matito +17 more
2020BMC Cancer53 citations Open access
Semantic Scholar
GEIS 2013 guidelines for gastrointestinal sarcomas (GIST)
A. Poveda, X. D. del Muro, J. López-Guerrero, V. Martínez +4 more
2014Cancer Chemotherapy and Pharmacology53 citations Open access
Semantic Scholar
Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function.
R. Morales-Barrera, J. Bellmunt, C. Suárez, C. Valverde +4 more
2012European Journal of Cancer53 citations
Semantic Scholar
Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors
C. Serrano, S. George, C. Valverde, D. Olivares +4 more
2017Targeted oncology52 citations
Semantic Scholar
Malignant bone tumors (other than Ewing’s): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS)
A. Redondo, S. Bagué, D. Bernabeu, E. Ortiz-Cruz +10 more
2017Cancer Chemotherapy and Pharmacology52 citations Open access
Semantic Scholar
Role of Surgery in Patients with Recurrent, Metastatic, or Unresectable Locally Advanced Gastrointestinal Stromal Tumors Sensitive to Imatinib: A Retrospective Analysis of the Spanish Group for Research on Sarcoma (GEIS)
J. Rubió-Casadevall, J. Martínez-Trufero, X. García-Albéniz, S. Calabuig +14 more
2015Annals of Surgical Oncology52 citations
Semantic Scholar
SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)
A. López-Pousa, J. Broto, J. M. Trufero, I. Sevilla +6 more
2016Clinical and Translational Oncology47 citations Open access
Semantic Scholar
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib
H. Joensuu, J. Blay, A. Comandone, J. Martin Broto +15 more
2017British Journal of Cancer41 citations Open access
Semantic Scholar
BRAF V600E and KRAS G12S mutations in peripheral nerve sheath tumours
C. Serrano, S. Simonetti, J. Hernández-Losa, C. Valverde +9 more
2013Histopathology37 citations
Semantic Scholar
Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer
Beatriz Paumard-Hernández, O. Calvete, Lucia Inglada Pérez, H. Tejero +22 more
2018International Journal of Cancer32 citations Open access
Semantic Scholar
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma
R. Alemany, D. Moura, A. Redondo, J. Martínez-Trufero +12 more
2018Clinical Cancer Research32 citations Open access
Semantic Scholar
SELNET Clinical practice guidelines for bone sarcoma.
J. Blay, E. Palmerini, J. Bollard, S. Aguiar +61 more
2022Critical reviews in oncology/hematology31 citations Open access
Semantic Scholar
Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward
M. J. Lostes-Bardaji, D. García-Illescas, C. Valverde, C. Serrano
2021Therapeutic Advances in Medical Oncology31 citations Open access
Semantic Scholar
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
J. Martin Broto, C. Valverde, N. Hindi, B. Vincenzi +23 more
2023Molecular Cancer29 citations Open access
Semantic Scholar
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.
R. Morales-Barrera, C. Suárez, A. M. D. de Castro, F. Racca +5 more
2016Cancer Treatment Reviews29 citations
Semantic Scholar
GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)
J. Mora, A. Castañeda, S. Perez-Jaume, A. López-Pousa +11 more
2017British Journal of Cancer27 citations Open access
Semantic Scholar
The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor.
R. Morales-Barrera, C. Suárez, Macarena González, C. Valverde +6 more
2020Cancer Treatment Reviews26 citations
Semantic Scholar
Working to improve the management of sarcoma patients across Europe: a policy checklist
B. Kasper, E. Lecointe-Artzner, S. Wait, S. Boldon +8 more
2018BMC Cancer22 citations Open access
Semantic Scholar
Identification of somatic gene mutations in penile squamous cell carcinoma
C. Ferrándiz-Pulido, J. Hernández-Losa, E. Masferrer, A. Vivancos +12 more
2015Genes, Chromosomes and Cancer22 citations
Semantic Scholar
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials.
A. Hernando-Calvo, M. Vila-Casadesús, Y. Bareche, Alberto Gonzalez-Medina +34 more
2023i Medicina17 citations Open access
Semantic Scholar
GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma
S. Gallego, D. Bernabeu, M. Garrido-Pontnou, G. Guillén +12 more
2021Clinical and Translational Oncology17 citations
Semantic Scholar
A DNA damage repair gene‐associated signature predicts responses of patients with advanced soft‐tissue sarcoma to treatment with trabectedin
D. Moura, M. Peña-Chilet, Juan Antonio Cordero Varela, R. Álvarez-Alegret +26 more
2021Molecular Oncology16 citations Open access
Semantic Scholar
Molecular basis for the treatment of renal cell carcinoma
C. Suárez, R. Morales, E. Muñoz, J. Rodón +2 more
2010Clinical and Translational Oncology16 citations
Semantic Scholar
Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients
E. González-Billalabeitia, D. Castellano, N. Sobrevilla, J. Gumà +23 more
2017Journal of the National Cancer Institute15 citations Open access
Semantic Scholar
Phase II clinical trial evaluating the activity and tolerability of pazopanib in patients (pts) with advanced and/or metastatic liposarcoma (LPS): A joint Spanish Sarcoma Group (GEIS) and German Interdisciplinary Sarcoma Group (GISG) Study—NCT01692496.
C. Valverde, J. Broto, J. López-Martín, C. Romagosa +12 more
201615 citations
Semantic Scholar
E3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumor
A. García-Valverde, J. Rosell, S. Sayols, D. Gómez-Peregrina +14 more
2021Oncogene13 citations
Semantic Scholar
Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor
A. García-Valverde, J. Rosell, G. Serna, C. Valverde +6 more
2020Molecular Cancer Therapeutics13 citations Open access
Semantic Scholar
IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib plus nivolumab in advanced soft tissue and bone sarcomas: Results of the phase II- soft-tissue sarcoma cohort
J. Broto, N. Hindi, G. Grignani, J. M. Trufero +14 more
2019Annals of Oncology13 citations Open access
Semantic Scholar
Role of Immunotherapy in Castration‐Resistant Prostate Cancer (CRPC)
C. Suárez, R. Morales-Barrera, V. Ramos, I. Núñez +5 more
2014BJU International13 citations
Semantic Scholar
Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib.
C. Serrano, X. Garcia-Del-Muro, C. Valverde, A. Sebio +18 more
2018The Oncologist12 citations Open access
Semantic Scholar
A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor
M. Pantaleo, M. Heinrich, A. Italiano, C. Valverde +10 more
2022BMC Cancer10 citations Open access
Semantic Scholar
SPEARHEAD-1: A phase II trial of ADP-A2M4 SPEAR T cells in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma.
D. Araujo, M. Druta, M. Agulnik, S. D'Angelo +9 more
2020Journal of Clinical Oncology10 citations
Semantic Scholar
Incidence and Clinical Pattern of Contralateral Synchronous and Metachronous Germ Cell Testicular Cancer.
P. Maroto, X. D. del Muro, C. Valverde, Á. Pinto +10 more
2020Urologic oncology10 citations
Semantic Scholar
Impact of immune-related adverse events on survival in patients with metastastic urothelial carcinoma treated with immune-checkpoint inhibitors.
R. Morales-Barrera, C. Suárez Rodriguez, Macarena González, J. Ros +15 more
2019Journal of Clinical Oncology9 citations
Semantic Scholar
Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy?
R. Morales-Barrera, C. Suárez, C. Valverde, I. Núñez +3 more
2013Clinical and Translational Oncology8 citations
Semantic Scholar
Emerging therapies for urothelial cancer.
C. Serrano, R. Morales, C. Suárez, I. Núñez +5 more
2012Cancer Treatment Reviews8 citations
Semantic Scholar
The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Analysis of overall survival in advanced synovial sarcoma.
B. Van Tine, K. Ganjoo, J. Blay, C. Valverde +16 more
2023Journal of Clinical Oncology7 citations
Semantic Scholar
Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID‐19 Pandemic
J. Martin Broto, N. Hindi, S. Aguiar, Ronald Badilla-Gonzalez +31 more
2020The Oncologist7 citations Open access
Semantic Scholar
Phase II trial of gemcitabine plus rapamycin as second line in advanced osteosarcoma: A Spanish Group for Sarcoma Research (GEIS) Study.
J. Broto, A. Redondo, C. Valverde, M. Salgado +10 more
20157 citations
Semantic Scholar
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)
I. Ray-Coquard, H. Hatcher, E. Bompas, A. Casado +15 more
2020International Journal of Gynecological Cancer6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Martin Broto×18
Invite
J. Martin Broto — researcher profile on SciRah
J. Carles×14
Invite
J. Carles — researcher profile on SciRah
N. Hindi×13
Invite
N. Hindi — researcher profile on SciRah
C. Serrano×13
Invite
C. Serrano — researcher profile on SciRah

J. Martínez-Trufero

×11

Invite

J. Martínez-Trufero — researcher profile on SciRah

A. López-Pousa×11

Invite

A. López-Pousa — researcher profile on SciRah

Invite

C. Suárez — researcher profile on SciRah

Invite

J. Blay — researcher profile on SciRah

Invite

A. Redondo — researcher profile on SciRah

Invite

D. Moura — researcher profile on SciRah

X. D. del Muro×8

Invite

X. D. del Muro — researcher profile on SciRah

E. de Álava×7

Invite

E. de Álava — researcher profile on SciRah